57 completed. 57 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 57 | Completed 57 |
| Phase 2 | 6 | Completed 6 |
Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 Dimolegin, Clexane - COVID-19, Venous Thromboembolism | Phase 3 | Completed | PharmaDiall Ltd. | 399 | 2021-02-08 | 2022-01-11 |
| Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events Rivaroxaban 20 MG [Xarelto], Aspirin 300mg, Acenocoumarol Oral Tablet - Venous Thromboembolism, Anticoagulant-induced Bleeding | Phase 2 / Phase 3 | Completed | Instituto Mexicano del Seguro Social | 58 | 2021-01-03 | 2022-08-25 |
| tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden The Bashir™ Endovascular Catheter, r-tPA - Pulmonary Embolism | Phase 3 | Completed | Thrombolex, Inc. | 109 | 2020-06-23 | 2023-04-20 |
| Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE) Oxygen gas - Pulmonary Embolism | Phase 3 | Completed | Ministry of Health, Spain | 70 | 2019-07-11 | 2022-08-18 |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Apixaban - Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Completed | Academic and Community Cancer Research United | 370 | 2017-07-14 | 2025-05-18 |
| PREVENTion of Clot in Orthopaedic Trauma Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH) - Blood Clot, Trauma | Phase 3 | Completed | Major Extremity Trauma Research Consortium | 12424 | 2017-04-24 | 2024-05-14 |
| Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Edoxaban, Standard of Care - Venous Thromboembolism (VTE), Pulmonary Embolism | Phase 3 | Completed | Daiichi Sankyo | 290 | 2017-03-27 | 2025-02-28 |
| Thrombolysis Endovascular Treatment of Pulmonary Embolism recombinant tissue plasminogen activator - Pulmonary Embolism, Acute Pulmonary Embolism | Phase 3 | Completed | Beijing Tsinghua Chang Gung Hospital | 50 | 2017-01-01 | 2020-11-30 |
| A Different Approach to Preventing Thrombosis VTE prophylaxis with Enoxaparin 30mg BID, VTE prophylaxis with Aspirin 81mg BID - Venous Thromboembolism, Pulmonary Embolism | Phase 3 | Completed | University of Maryland, Baltimore | 329 | 2016-01-01 | 2022-01-05 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Apixaban, Dalteparin, Questionnaire Administration - Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Completed | Academic and Community Cancer Research United | 300 | 2015-11-20 | 2020-08-04 |
| Cancer Venous Thromboembolism (VTE) Edoxaban, Dalteparin, Low molecular weight heparin - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Phase 3 | Completed | Daiichi Sankyo | 1046 | 2015-07-16 | 2019-03-06 |
| Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) BAY 59-7939, ASA - Pulmonary Embolism, Thromboembolism | Phase 3 | Completed | Bayer | 3365 | 2014-03-05 | 2017-12-19 |
| AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients Apixaban, Unfractionated Heparin (UFH), Warfarin - Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Completed | Pfizer | 80 | 2013-01-01 | 2016-06-23 |
| Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy recombinant tissue plasminogen activator, EKOS EkoSonic Endovascular System - Pulmonary Embolism, Acute Pulmonary Embolism | Phase 3 | Completed | Boston Scientific Corporation | 150 | 2012-06-07 | 2021-07-19 |
| Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients Rivaroxaban (Xarelto, BAY59-7939), Unfractionated heparin, Warfarin - Pulmonary Embolism | Phase 3 | Completed | Bayer | 40 | 2012-02-01 | 2017-01-23 |
| Simplification of the Diagnosis of Deep Vein Thrombosis Extensive search for isolated calf DVT - Deep Venous Thrombosis | Phase 3 | Completed | University of Padova | 1100 | 2011-03-01 | 2015-01-26 |
| ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism EkoSonic Endovascular System, Unfractionated heparin - Submassive Pulmonary Embolism | Phase 3 | Completed | Boston Scientific Corporation | 59 | 2010-07-01 | 2021-07-19 |
| Crux Biomedical Vena Cava Filter Study - United States Inferior Vena Cava Filter - Pulmonary Embolism | Phase 3 | Completed | Crux Biomedical | 88 | 2010-06-01 | 2014-06-30 |
| Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3") Inferior Vena Cava Filter - Pulmonary Embolism | Phase 3 | Completed | Crux Biomedical | 17 | 2010-05-01 | 2014-06-30 |
| Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4 Inferior Vena Cava Filter - Pulmonary Embolism | Phase 3 | Completed | Crux Biomedical | 20 | 2010-05-01 | 2014-06-30 |
Showing 20 of 57. Sign in to see all of them.
Pulmonary Embolism (48) · Venous Thrombosis (32) · Venous Thromboembolism (23) · Thrombosis (9) · Thromboembolism (8) · Atrial Fibrillation (4) · Hemorrhage (3) · Neoplasms (3) · Stroke (3) · Intracranial Thrombosis (2) · Neoplasm Metastasis (2) · Arrhythmias, Cardiac (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1)
Cardiovascular Diseases (57) · Embolism and Thrombosis (57) · Vascular Diseases (57) · Respiratory Tract Diseases (48) · Lung Diseases (47) · Thrombosis (25) · Thromboembolism (19) · Pathological Conditions, Signs and Symptoms (11) · Pathologic Processes (10) · Brain Diseases (7) · Central Nervous System Diseases (7) · Nervous System Diseases (7) · Cerebrovascular Disorders (6) · Heart Diseases (5)
Warfarin (12) · Enoxaparin (11) · Heparin (8) · apixaban (8) · Rivaroxaban (6) · edoxaban (6) · Fondaparinux (5) · Heparin, Low-Molecular-Weight (5) · Dalteparin (4) · Aspirin (3) · Vena Cava Filters (3) · enoxaparin sodium (3) · Tissue Plasminogen Activator (2) · acarboxyprothrombin (2) · idraparinux (2)
Bristol-Myers Squibb (5) · Bayer (4) · Daiichi Sankyo (4) · Sanofi (4) · Crux Biomedical (3) · GlaxoSmithKline (3) · McMaster University (3) · Academic and Community Cancer Research United (2) · Assistance Publique - Hôpitaux de Paris (2) · Boston Scientific Corporation (2) · Daiichi Sankyo Co., Ltd. (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · University of Padova (2) · ARCA Biopharma, Inc. (1) · Abbott RDx Cardiometabolic (1)
United States (31) · Canada (20) · France (19) · Australia (17) · Belgium (17) · Spain (17) · Denmark (16) · Germany (16) · Italy (16) · Poland (16) · Brazil (14) · Hungary (14) · Israel (14) · Norway (14) · Russia (14)
Jim Julian, MMath (3) · Takeshi Fuji (2) · Abass Alavi (1) · Alan Maisel, MD (1) · Barry S Weinstock, MD (1) · Brian Firth, MD, PhD, MBA, FACC (1) · Charles Hales (1) · Clive Kearon, MB Ph.D (1) · Clive Kearon, MD (1)
PMID 35570249, PMID 40163217, PMID 22863355, PMID 23279103, PMID 28617144, PMID 28762617, PMID 40925065, PMID 15262836, PMID 16531616, PMID 16926353, PMID 17498584, PMID 17723125, PMID 17855670, PMID 17855671, PMID 18838564, PMID 19233855, PMID 19293071, PMID 19348685, PMID 19657123, PMID 19854398, PMID 20206776, PMID 20211293, PMID 20448094, PMID 20516378, PMID 20934556, PMID 20950224, PMID 21083927, PMID 21175312, PMID 21359646, PMID 21703676, PMID 21830957, PMID 21861537, PMID 22077144, PMID 22130488, PMID 22172434, PMID 22284935, PMID 22371186, PMID 22398655, PMID 22402056, PMID 22431865, PMID 22449293, PMID 22450429, PMID 23212720, PMID 23318311, PMID 23388003, PMID 23500298, PMID 23525418, PMID 23723250, PMID 23778903, PMID 23829521
2014 (1), 2016 (1), 2019 (1), P30CA015083 (1), R01HL085565 (1), R42HL086316 (1)